(JYNT) The Joint - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US47973J1025
JYNT: Chiropractic, Care, Services, Treatments, Wellness, Health
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona. Web URL: https://www.thejoint.com
Additional Sources for JYNT Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
JYNT Stock Overview
| Market Cap in USD | 155m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception | 2014-11-11 |
JYNT Stock Ratings
| Growth 5y | -33.8% |
| Fundamental | 21.5% |
| Dividend | - |
| Rel. Strength Industry | 539 |
| Analysts | 4/5 |
| Fair Price Momentum | 9.74 USD |
| Fair Price DCF | 9.97 USD |
JYNT Dividends
No Dividends PaidJYNT Growth Ratios
| Growth Correlation 3m | -58.1% |
| Growth Correlation 12m | -16.3% |
| Growth Correlation 5y | -57.1% |
| CAGR 5y | -5.95% |
| CAGR/Mean DD 5y | -0.11 |
| Sharpe Ratio 12m | 0.53 |
| Alpha | -18.49 |
| Beta | 1.62 |
| Volatility | 52.83% |
| Current Volume | 58.5k |
| Average Volume 20d | 53.6k |
What is the price of JYNT stocks?
As of January 22, 2025, the stock is trading at USD 11.40 with a total of 58,518 shares traded.
Over the past week, the price has changed by +11.55%, over one month by +13.21%, over three months by -1.98% and over the past year by +21.41%.
As of January 22, 2025, the stock is trading at USD 11.40 with a total of 58,518 shares traded.
Over the past week, the price has changed by +11.55%, over one month by +13.21%, over three months by -1.98% and over the past year by +21.41%.
Is The Joint a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, The Joint is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.47 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JYNT as of January 2025 is 9.74. This means that JYNT is currently overvalued and has a potential downside of -14.56%.
Neither. Based on ValueRay Fundamental Analyses, The Joint is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.47 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JYNT as of January 2025 is 9.74. This means that JYNT is currently overvalued and has a potential downside of -14.56%.
Is JYNT a buy, sell or hold?
The Joint has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy JYNT.
The Joint has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy JYNT.
- Strong Buy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for JYNT stock price target?
According to ValueRays Forecast Model, JYNT The Joint will be worth about 11 in January 2026. The stock is currently trading at 11.40. This means that the stock has a potential downside of -3.42%.
According to ValueRays Forecast Model, JYNT The Joint will be worth about 11 in January 2026. The stock is currently trading at 11.40. This means that the stock has a potential downside of -3.42%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 16.4 | 43.7% |
| Analysts Target Price | 16.4 | 43.7% |
| ValueRay Target Price | 11 | -3.4% |